Intimation of schedule of Analysts/Investors Earning call for the Quarter-1 ended on June 30, 2026.

OrchidPharm~W -- A Dhanuka Group Company ---------------------------------- August 17, 2026 National Stock Exchange of India Limited, BSE Limited Exchange Plaza, Bandra Kurla Complex Phiroze Jeejeebhoy Towers, Bandra (E), Mumbai- 400051 Dalal Street, Fort, Mumbai- 400001 Symbol: ORCHPHARMA Scrip Code: 524372 Ref: (i) Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (ii)SEBI Master Circular No. SEBI/HO/49/14/14(7)2025-CFD- POD2/1/3762/2026 dated January 30, 2026 Sub: Intimation of schedule of Ana Iysts I Investors Earning Call for the Ouarter I ended on June 30, 2026 Dear Sir/Madam, In reference to the captioned subject and pursuant to Regulation 30 read with Sub-Para 15, Para A of Part A of Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, read with SEBI Master Circular No. SEBI/HO/49/14/14(7)2025-CFD-POD2/1/3762/2026 dated January 30, 2026, this is to intimate that an Analysts/Investors Earning Call hosted by 'Systematix Institutional Equities' is scheduled to be held on Friday, August 21, 2026 at 03:00 P.M. (1ST) to discuss the financial results/ performance of the Company for the Quarter-I ended on June 30, 2026. The aforesaid information will also be hosted on the Company's website at www.orchidpharma.com Note: The schedule may undergo change due to exigencies on the part of the Analysts/Investors/Company and will be informed, if so. The invite of the Analysts/Investors Earning Call is enclosed herewith. You are requested to take the above intimation on record. Thanking You, For Orchid Pharma Limited Kapil Dayya Company Secretary & Compliance Officer Mem. No. Fl0698 Encl.: as above +91-44-27444471/72/73 corporate@orchidpharma.com orchidpharma.com CIN: L24222TN1992PLC022994 Registered Office: Corporate Office: Orchid Pharma Limited 15th Floor, Tower 1. DLF Corporate Greens, Sector 74A. Plot Nos. 121-128, 128A-133, 138-151,159-164, SIDCO Industrial Estate, Gurugram - 122004, Haryana, India Alathur, Chengalpattu Dist - 603110, Tamil Nadu, India. SYSTEMATIX INSTITUTIONAL EQUITIES Invites you to participate in Q1FY27 Results Conference Call of Orchid Pharma Limited On Friday, 21st August 2026 at 3:00 PM (IST) The management will be represented by Mr. Manish Dhanuka Mr. Mridul Dhanuka Mr. Sunil Kumar Gupta Managing Director Whole Time Director Chief Financial Officer Dial-in-number Location Dial Number Location Toll Free Number USA : 1 866 746 2133 Primary Number +91 22 6280 1297 UK : 0 808 101 1573 Singapore : 800 101 2045 Secondary Number +91 22 7115 8198 Hong Kong : 800 964 448 Click here for your Diamond Pass™ https://services.choruscall.in/DiamondPassRegistration/register?confirmationNumber=4900090&linkSecurityString=2a93fb7d50 DiamondPass™ is a Premium Service that enables you to connect to your conference call without having to wait for an operator. For more information, please contact: Vishal Manchanda Mrunal Pawar Equity Research Analyst Senior VP & Group Head - Corporate Access & Contact No: +91 97374 37148 Corporate Communication vishalmanchanda@systematixgroup.in Contact No: + 91 22 6704 8088 mrunalpawar@systematixgroup.in